Mabion S.A. (WSE:MAB)

Poland flag Poland · Delayed Price · Currency is PLN
8.57
-0.12 (-1.38%)
Oct 10, 2025, 5:00 PM CET
-1.38%
Market Cap138.51M
Revenue (ttm)11.24M
Net Income (ttm)-64.84M
Shares Out16.16M
EPS (ttm)-4.01
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume15,723
Average Volume42,156
Open8.72
Previous Close8.69
Day's Range8.53 - 8.78
52-Week Range8.00 - 16.56
Beta0.32
RSI44.07
Earnings DateSep 12, 2025

About Mabion

Mabion S.A., a biopharmaceutical company, provides services as a contract development and manufacturing organization in the process development, analytics, and manufacturing of biologic medicines in Poland. It offers drug substance manufacturing, fill and finish, gene to vial: end-to-end development, process development, analytics, and cell line development and banking services. The company was founded in 2007 and is headquartered in Konstantynów Lódzki, Poland. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2007
Employees 213
Stock Exchange Warsaw Stock Exchange
Ticker Symbol MAB
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.